All News
RheumNow Podcast – Up, Down & Turned Around (12.18.20)
Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Read Article
ACIP Recommendations for Pfizer-BioNTech COVID-19 Vaccine Use (including Special Populations)
CDC/MMWR
Following the FDA issuance of an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for the prevention of COVID-19 in persons aged ≥16 years.
Read Article
Encouraging Rheumatology Fellowship Match for 2021
JJ Cush and ACR Press Release
The results of the National Residents Matching Program (NRMP) match in rheumatology are out and show that rheumatology fellowship was both competitive and highly sought after.
Read Article
ACIP Recommendations for Pfizer-BioNTech COVID-19 Vaccine Use (including Special Populations)
https://t.co/Q15gQRWGhg https://t.co/Jk1PbRzMtT
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out the RheumNow podcast on Soundcloud and Apple/Android devices.
This weeks--Up, Down & Turned Around. We review the news and journal articles from the last week on the site.
https://t.co/n4PQKVfHlb https://t.co/HXr4I21Vzk
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatology Roundup #ACR20
https://t.co/uov1DwNxsn https://t.co/DDF4mzfPwr
Links:
Dr. John Cush RheumNow ( View Tweet)
New podcast up! COVID Vaccine Q & A - Dr Kevin Winthrop
https://t.co/EJL6hVLnrp https://t.co/3oriO09PBU
Links:
Dr. John Cush RheumNow ( View Tweet)
New ACR RA Guidelines and Practice Changing Abstracts: Panel
Panelists include Dr.Kathryn Dao ( @KDAO2011), Dr. Eric Dein ( @ejdein1), Dr. Meral El Ramahi ( @MeralElRamahiMD), Dr. Richard Conway ( @RichardPAConway) + Dr. Sheila Reyes( @RHEUMarampa) #ACR20
https://t.co/WEgQpwUlC6 https://t.co/zFiXtzsHGB
Links:
Dr. John Cush RheumNow ( View Tweet)
COVID: DMARDs, Steroids, a Vaccine - and how long will this continue? Dr. Winthrop reviews all things COVID-related including abstract L01, steroids and DMARDs, vaccination status - and how long this pandemic will last. #ACR20
https://t.co/KWq5ey5Kcf https://t.co/QKFZVnrMpD
Links:
Dr. John Cush RheumNow ( View Tweet)
Cardiovascular Risk on MTX in Rheumatoid Arthritis: Dr. Jonathan Kay offers his view of an important question for a large group of RA patients. #acr20
https://t.co/4TS9BI6fOK https://t.co/FZFvsIpcHA
Links:
Dr. John Cush RheumNow ( View Tweet)
Encouraging Rheumatology Fellowship Match for 2021
https://t.co/DwAs47pgi5 https://t.co/Dl27nI3QlE
Links:
Dr. John Cush RheumNow ( View Tweet)
Panelists Dr. David Liew, Dr. Laura Cappelli, Dr. Cassandra Calabrese and Dr. Karmela Kim Chan discuss iRAE sessions and studies. #ACR20
https://t.co/3FpAGsSo9m https://t.co/r2qO5tYxR4
Links:
Dr. John Cush RheumNow ( View Tweet)
COVID-19–related mortality rates has become a leading cause of death according to statistics from the Centers for Disease Control and Prevention.
Read more here https://t.co/KhrbLce2Q1 https://t.co/fQQ0suzA2A
Links:
Dr. John Cush RheumNow ( View Tweet)
How FAST can you go? with Dr. Michael Pillinger #acr20
https://t.co/YV2lyAAEyY https://t.co/bycb4KHf9S
Links:
Dr. John Cush RheumNow ( View Tweet)
Benlysta First Agent Approved for Lupus Nephritis: GlaxoSmithKline announced yesterday that the FDA has approved belimumab (Benlysta) for use in adults with active lupus nephritis (LN) receiving background/standard therapy.
https://t.co/O7CBAn55t2 https://t.co/RWNDzUqxhM
Links:
Dr. John Cush RheumNow ( View Tweet)
Herpes Zoster on the Brain and Vaccinations with Dr Kevin Winthrop #ACR20
https://t.co/XdQO1ztD1I
Links:
Dr. John Cush RheumNow ( View Tweet)
Early view in ACR Open Access:
Patient Perspectives on Gout and Gout Treatments: A Patient Panel Discussion That Informed the 2020 American College of Rheumatology Treatment Guideline
https://t.co/QY6pofhamT
ACR_Journals ACR_Journals ( View Tweet)
Filgotinib Bows Out of the RA Race in the USA--Gilead Sciences Inc announced yesterday that it has decided not to pursue the rheumatoid arthritis (RA) indicatin for its once daily oral JAK inhibitor, filgotinib (also named Jyseleca).
https://t.co/XAR3T8AQpR https://t.co/GlQB9L8Jnd
Links:
Dr. John Cush RheumNow ( View Tweet)
Checkout Dr. Kevin Winthrops RheumNow interview for insights and caveats on the use of COVID-19 vaccination in patients with rheumatic disease and those taking biologics or DMARDs. To hold MTX or not? https://t.co/C1fgCcKgWZ
Links:
Dr. John Cush RheumNow ( View Tweet)
Everyone (Docs and patients) should watch this great video by Dr. Aggarwal from UPitt -he reviews the COVID-19 vaccines, differences, risks and compares to other vaccines https://t.co/j9iqxdgXnL
Dr. John Cush RheumNow ( View Tweet)
